GWSG
ABBV icon

GPS Wealth Strategies Group’s AbbVie ABBV Stock Holding History

GPS Wealth Strategies Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$751K Sell
3,287
-8,787
-73% -$2M 0.64% 37
2025
Q3 		$2.8M Sell
12,074
-308
-2% -$62.7K 0.3% 59
2025
Q2 		$2.3M Sell
12,382
-159
-1% -$29.6K 0.26% 62
2025
Q1 		$2.63M Sell
12,541
-140
-1% -$27.2K 0.35% 50
2024
Q4 		$2.25M Sell
12,681
-763
-6% -$140K 0.29% 57
2024
Q3 		$2.65M Sell
13,444
-275
-2% -$51.3K 0.35% 49
2024
Q2 		$2.35M Buy
13,719
+102
+0.7% +$16.9K 0.35% 50
2024
Q1 		$2.48M Sell
13,617
-131
-1% -$22.6K 0.4% 46
2023
Q4 		$2.13M Buy
13,748
+389
+3% +$56.7K 0.39% 55
2023
Q3 		$1.99M Sell
13,359
-16,977
-56% -$2.49M 0.38% 55
2023
Q2 		$4.09M Sell
30,336
-511
-2% -$74.9K 0.76% 26
2023
Q1 		$4.92M Buy
30,847
+251
+0.8% +$38.4K 1.02% 17
2022
Q4 		$4.97M Buy
30,596
+265
+0.9% +$40.6K 1.49% 16
2022
Q3 		$4.07M Buy
30,331
+179
+0.6% +$25.7K 1.03% 17
2022
Q2 		$4.62M Buy
30,152
+2,426
+9% +$371K 1.19% 11
2022
Q1 		$4.5M Buy
27,726
+1,508
+6% +$219K 1.02% 15
2021
Q4 		$3.55M Buy
26,218
+65
+0.2% +$7.68K 0.78% 22
2021
Q3 		$2.82M Buy
26,153
+590
+2% +$67.4K 0.7% 25
2021
Q2 		$2.88M Buy
25,563
+2,613
+11% +$294K 0.73% 21
2021
Q1 		$2.48M Buy
22,950
+10,147
+79% +$1.09M 0.73% 21
2020
Q4 		$1.37M Buy
12,803
+1,773
+16% +$170K 0.48% 37
2020
Q3 		$966K Buy
+11,030
New +$1.04M 0.39% 47

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

GPS Wealth Strategies Group's ABBV Position: Q4 2025 in Review

GPS Wealth Strategies Group reduced its AbbVie (ABBV) stake by 73% in Q4 2025, selling an estimated $2M and leaving 3,287 shares worth $751K. The position accounts for 0.64% of the portfolio, ranked #37.

GPS Wealth Strategies Group first reported a position in ABBV in Q3 2020 and has held it in 22 quarters since. The position peaked at $4.97M in Q4 2022. 4,145 funds tracked by Wall St. Rank hold ABBV as of Q4 2025.

  • GPS Wealth Strategies Group held 3,287 shares of AbbVie worth $751K as of Q4 2025.
  • GPS Wealth Strategies Group sold 8,787 AbbVie shares in Q4 2025, an estimated $2M.
  • AbbVie made up 0.64% of GPS Wealth Strategies Group's portfolio in Q4 2025, its #37 holding.
  • GPS Wealth Strategies Group first reported a position in AbbVie in Q3 2020 and has held it in 22 quarters since.
  • GPS Wealth Strategies Group's AbbVie position peaked at $4.97M in Q4 2022.
  • 4,145 funds tracked by Wall St. Rank held AbbVie as of Q4 2025.

Based on GPS Wealth Strategies Group's 13F filing for Q4 2025, filed 6 Feb 2026.